N. Dufeu

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

L. Dupont, H. Janssens, S. van Koningsbruggen-Rietschel, 2021, Trials.

Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung

C. Auffray, R. Slama, J. Vincent, 2017, The Journal of allergy and clinical immunology.

T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction

J. Vincent, Y. Castier, A. Didier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Blood CD9+ B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation

R. Slama, Y. Castier, J. Pellet, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Transplantation pulmonaire: Lung transplantation

M. Reynaud‐Gaubert, B. Coltey, Carine Gomez, 2014 .

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

J. Benichou, P. Reix, I. Pin, 2021, Pulmonary Therapy.

Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients

J. Rolain, M. Reynaud‐Gaubert, P. Thomas, 2018, BMC Microbiology.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant

P. Burgel, I. Durieu, I. Sermet-Gaudelus, 2023, European Respiratory Journal.

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report.

M. Reynaud‐Gaubert, J. Gaubert, M. Di Bisceglie, 2022, European journal of radiology.

Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia

B. Housset, P. Burgel, J. Papon, 2016, Thorax.

Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey.

J. Dubus, L. Vecellio, B. Delaisi, 2017, Pulmonary pharmacology & therapeutics.

Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases

M. Laine, N. Resseguier, M. Reynaud‐Gaubert, 2023, ERJ Open Research.

Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction

S. Delliaux, O. Collange, F. Daviet, 2024, Respiratory research.